(Q54649699)

2 June 2018

title

The Fibroblast Growth Factor Receptor-4 Arg388 Allele is Associated with Gastric Cancer Progression (English)

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

14 July 2024

author name string

Yanwei Ye

1

1 reference

2 June 2018

Yingqiang Shi

2

1 reference

2 June 2018

Ye Zhou

3

1 reference

2 June 2018

Chunyan Du

4

1 reference

2 June 2018

Chunmeng Wang

5

1 reference

2 June 2018

Heqin Zhan

6

1 reference

2 June 2018

Biqiang Zheng

7

1 reference

2 June 2018

Xi Cao

8

1 reference

2 June 2018

Meng-Hong Sun

9

1 reference

2 June 2018

Hong Fu

10

1 reference

2 June 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20844967

14 July 2024

publication date

16 September 2010

1 reference

2 June 2018

full work available at URL

http://www.annalssurgicaloncology.org/cgi/content/abstract/17/12/3354

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20844967

http://link.springer.com/content/pdf/10.1245/s10434-010-1323-6.pdf

14 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

http://link.springer.com/article/10.1245/s10434-010-1323-6/fulltext.html

14 July 2024

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

http://link.springer.com/content/pdf/10.1245/s10434-010-1323-6

14 July 2024

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Annals of Surgical Oncology

14 July 2024

published in

1 reference

2 June 2018

volume

17

1 reference

2 June 2018

issue

12

1 reference

2 June 2018

page(s)

3354-3361

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1245/s10434-010-1323-6

exact match

0 references

cites work

Role of fibroblast growth factor receptor signaling in prostate cancer cell survival.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1323-6

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

The FGF family of growth factors and oncogenes

14 July 2024

2

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Cellular signaling by fibroblast growth factor receptors

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Liver-specific activities of FGF19 require Klotho beta

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer

14 July 2024

10

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer

14 July 2024

12

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma

14 July 2024

14

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma

14 July 2024

15

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population

14 July 2024

16

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.

14 July 2024

17

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis

14 July 2024

19

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis

14 July 2024

20

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.

14 July 2024

21

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development

14 July 2024

22

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention

14 July 2024

23

1 reference

https://api.crossref.org/works/10.1245/S10434-010-1323-6

14 July 2024

Identifiers

1 reference

2 June 2018

Dimensions Publication ID

1044024228

0 references

1 reference

2 June 2018